News Samsung Bioepis Reports the US FDA’s approval of Ospomyv & Xbryk (Biosimilar, Prolia & Xgeva)ByRidhi RastogiFebruary 16, 20250Comments
Weekly Snapshot PharmaShots Weekly Snapshots (February 10th, 2025 – February 14th, 2025)BySenior EditorFebruary 14, 20250Comments
News IDEAYA Enters Into an Additional Clinical Study Collaboration and Supply Agreement with Gilead SciencesByRidhi RastogiFebruary 14, 20250Comments
News Galderma’s Nemluvio (Nemolizumab) Secures the EU Approval to Treat Moderate-To-Severe Atopic Dermatitis (AD) and Prurigo nodularis (PN)ByRidhi RastogiFebruary 14, 20250Comments
News Sanofi and J&J Discontinue P-III (E.mbrace) Study of ExPEC9V for Invasive E. coli DiseasesByRidhi RastogiFebruary 14, 20250Comments
News Bayer Submits MAA of Finerenone to Japan’s MHLW for Heart Failure (HF)ByRidhi RastogiFebruary 14, 20250Comments
News Pfizer Reports Data from P-III (TALAPRO-2) Trial of Talzenna + Xtandi for Metastatic Castration Resistant Prostate Cancer (mCRPC)ByRidhi RastogiFebruary 14, 20250Comments
